Song et al. reported AMPK-promoted cancer cells ferroptosis by mediating BECN1 phosphorylation and BECN1-SLC7A11 complex formation [19], which is consistent with our finding that ferroptosis inhibitors downregulate BCAT2 expression through activating AMPK. The gene discussed is SLC7A11; the disease is cancer.